Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease
People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the U.K. and Vertex.
Related Articles
Five Key Risk Factors for Osteoporosis
Endocrinologist Dr José Gotés Palazuelos from Mexico City outlines key risk factors for osteoporosis that clinicians should keep in mind.
Former Google, Meta leaders launch Palona AI, bringing personalized, emotive customer agents to non-techie enterprises
Palona’s approach suggests that customer relationships don’t have to be sacrificed for automation—instead, AI can enhance personalization.
How Do We Review Technologies? – The Medical Futurist
Health sensors, trackers, AI technologies, and genetic tests are the air we breathe. Read about The Medical Futurist’s review policy in detail
Teaching residents what to do when patients don’t take their meds
Medication nonadherence is costly and deadly and frustrates even seasoned physicians. An online training covers how to tackle this common problem.
This cool tech will turn existing fiber optics into smart sensors on Minnesota’s grid
Great River Energy has partnered with Prisma Photonics to roll out monitoring technology on Minnesota’s grid using existing fiber optics.
How Does Alcohol Affect Sleep?
Can a boozy nightcap help you sleep better? Not exactly, says our sleep disorders specialist. Here’s why.
Современный взгляд на методы хирургического лечения кистозного эхинококкоза печени | Бояринов | Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»
Echinococcosis of the liver is an important problem of hematology, which in many cases is solved only with the help of surgical methods of treatment.…
Scratching an itch is so good, and so bad
Scratching an itch can bring a contradictory wave of pleasure and misery. A mouse study on scratching, reported in the Jan. 31 Science, fleshes out…
Apple CEO Tim Cook: There’s a ‘Lot of Innovation’ Left for Future iPhone Development
During today’s earnings call covering the first fiscal quarter of 2025, Apple CEO Tim Cook was asked about whether he felt there was room for…